Oncoproteomics: New trends in analytical techniques

Girish Gupta1, Nikhil Gupta2, Mayank Gupta3, Soham Trivedi4, Prasad Patil5, Vamsi Krishna K6, Hipal Gaudani7, Gomase V.S.8
1S.D.S.M. College Palghar, Mumbai
2Sindhu Mahavidyalaya Panchpaoli Nagpur
3Sindhu Mahavidyalaya Panchpaoli Nagpur
4V.V.P. Engineering College, Rajkot, Gujrat
5Dr. D.Y. Patil ACS College, Pimpri, Pune
6Rai foundations College CBD Belapur Navi Mumbai
7V.V.P. Engineering College, Rajkot, Gujrat
8School of Technology, S.R.T.M. University, Sub-Centre, Latur, 413512, India

Received : -     Accepted : -     Published : 21-12-2009
Volume : 1     Issue : 2       Pages : 5 - 9
Int J Drug Discov 1.2 (2009):5-9
DOI : http://dx.doi.org/10.9735/0975-4423.1.2.5-9

Keywords : Oncoproteomics, Genomics, Proteomics, NMR, MS, GC
Conflict of Interest : None declared

Cite - MLA : Girish Gupta, et al "Oncoproteomics: New trends in analytical techniques." International Journal of Drug Discovery 1.2 (2009):5-9. http://dx.doi.org/10.9735/0975-4423.1.2.5-9

Cite - APA : Girish Gupta, Nikhil Gupta, Mayank Gupta, Soham Trivedi, Prasad Patil, Vamsi Krishna K, Hipal Gaudani, Gomase V.S. (2009). Oncoproteomics: New trends in analytical techniques. International Journal of Drug Discovery, 1 (2), 5-9. http://dx.doi.org/10.9735/0975-4423.1.2.5-9

Cite - Chicago : Girish Gupta, Nikhil Gupta, Mayank Gupta, Soham Trivedi, Prasad Patil, Vamsi Krishna K, Hipal Gaudani, and Gomase V.S. "Oncoproteomics: New trends in analytical techniques." International Journal of Drug Discovery 1, no. 2 (2009):5-9. http://dx.doi.org/10.9735/0975-4423.1.2.5-9

Copyright : © 2009, Girish Gupta, et al, Published by Bioinfo Publications. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Abstract

Oncoproteomics is the study of proteins and their interactions in a cancer cell by proteomic technologies and has the potential to revolutionize clinical practice, including cancer diagnosis. Oncoproteomics screening based on proteomic platforms as a complement to histopathology, individualized selection of therapeutic combinations that target the entire cancer-specific protein network, real-time assessment of therapeutic efficacy and toxicity and rational modulation of therapy based on changes in the cancer protein network associated with prognosis and drug resistance. Oncoproteomics refers to the application of proteomic technologies in oncology and parallels the related field of oncogenomics. The challenges ahead and perspectives of oncoproteomics for biomarkers development are also addressed. With a wealth of information that can be applied to a broad spectrum of biomarker research projects serves as a reference for biomarker researchers, scientists working in proteomics and bioinformatics, oncologists, pharmaceutical scientists, biochemists, biologists, and chemists.

References

[1] Alhamdani M.S., Schroder C., Hoheisel J.D. (2009) Genome Med., 1(7),68  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[2] Cho W.C. (2007) Mol Cancer. 2; 6:25.  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[3] Cho W.C. (2007) Mol Cancer. 2; 6:25.  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[4] Haab B.B. (2003) Proteomics. 3(11):2116- 22.s  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[5] Borrebaeck C.A. (2006) Expert Opin Biol Ther. 6(8):833-8.  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[6] Mafcgregor P.F. (2003) Expert Rev Mol Diagn. 3(2):185-200  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[7] Wingren C., Borrebaeck C.A. (2007) Expert Rev Mol Diagn. 7(5):673-86.  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[8] Sreekumar A., Chinnaiyan A.M. (2002) Curr Opin Mol Ther. 4(6):587-93.  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[9] Yip T.T., Lomas L. (2002) Technol Cancer Res Treat. 1(4):273-80.  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[10] Ramon Aragues , Chris Sander and Baldo Oliva. (2008) BMC Bioinformatics. 9:172  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[11] Kumar S., Mohan A. and Guleria R. (2006) Biomarkers. 11(5):385-405  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[12] Kumar S., Mohan A. and Guleria R. (2006) Biomarkers. 11(5):385-405  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[13] Wingren C., Borrebaeck C.A. (2006) OMICS. 10(3):411-27  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[14] DeVita V.T. Jr., Bleickardt E.W. (2001) Cancer J. 7 Suppl 1:S2-13.  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[15] Gagnon A., Ye B. (2008) Curr Opin Obstet Gynecol. 20(1):9-13  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[16] Alessandro R., Fontana S., Kohn E., De Leo G. (2005) Tumori. 91(6):447-55  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[17] Sun S., Lee N.P., Poon R.T., Fan S.T., He Q.Y., Lau G.K., Luk J.M. (2007) Liver Int. 27(8):1021-38.  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[18] Jain K.K. (2005) Expert Opin Pharmacother. 6(9):1463-76  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[19] Jain K.K. (2004) Expert Rev Proteomics. 1(1):49-55  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[20] Jain K.K. (2002) Technol Cancer Res Treat. 1(4):219-20.  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[21] Jain K.K. (2002) Curr Opin Mol Ther. 4(3):203-9  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[22] McHugh S.M., O'Donnell J., Gillen P. (2009) World J Surg Oncol. 7:36.  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[23] Alessandro R., Fontana S., Kohn E., De Leo G. (2005) Tumori.91(6):447-55  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[24] Espejel F., Roa J.C. (2008) Med Clin (Barc). 131(8):312-7.  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[25] Jain K.K. (2008) Mol Oncol. 2(2):153-60.  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[26] Matta A., DeSouza L.V, Shukla N.K, Gupta S.D., Ralhan R., Siu K.W. (2008) J Proteome Res. 7(5):2078-87  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[27] Roboz J. (2005) Cancer Invest. 23(5):465- 78.  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[28] Cho W.C, Cheng CH. (2007) Expert Rev Proteomics. 4(3):401-10  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[29] Jain K.K. (2007) J Buon. 12 Suppl 1:S31-8  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[30] Verma M., Wright G.L. Jr., Hanash S.M., Gopal-Srivastava R., Srivastava S. (2001) Ann N Y Acad Sci., 945:103-15.  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus